REFERENCES
- Albrechtsen, O. K. Fibrinolytic activity in the organism. Acta physiol, scand. 1959, 47, Suppl. 165.
- Almersjö, O., Bengmark, S., Engevik, L., Korsan-Bengtsen, K. & Ygge, J. The coagulation defect after extensive liver resection in man. Scand. J. Gastroent. 1967, 2, 204–208.
- Astrup, T., Rasmussen, J. & Amery, A. Fibrinolytic activity of cirrhotic liver. Nature (Lond.) 1960, 185, 619–620.
- Barnhart, M. I. & Forman, W. B. The cellular localization of fibrinogen as revealed by the fluorescent antibody technique. Vox Sang. (Basel) 1963, 8, 461–473.
- Collen, D. & Verstraete, M. Metabolism of plasminogen in clinical conditions with activation of the fibrinolytic system, p. 116 in II Congr. Int. Soc. Thromb. Haemost., Oslo, 1971. Abstract volume.
- Egeberg, O. Antihemophilic A factor (factor VIII) and fibrinogen in human blood. Scand. J. clin. Lab. Invest. 1962, 14, 230–234.
- Fiatmark, A., Rö, J. S., Jakobsen, A., Jr., Enge, I. & Skrede, S. Regeneration and metabolic changes following extensive liver resection in dogs. Scand. J. Gastroent. 1973, 8, 609–613.
- Highsmith, R. F. & Kline, D. L. Kidney: primary source of plasminogen after acute depletion in the cat. Science 1971, 174, 141–142.
- Mainland, D. Elementary Medical Statistics Saunders Co., Philadelphia & London, 1963.
- Mattii, R., Ambrus, J. L., Sokal, J. E. & Mink, I. Production of members of the blood coagulation and fibrinolysin systems by the isolated perfused liver. Proc. Soc. exp. Biol. (N.Y.) 1964, 116, 69–72.
- Niléhn, J.-E., Aronsen, K.-F. & Ericsson, B. Changes in blood clotting factors after massive liver resection and total hepatectomy in dogs. Acta chir. scand. 1967, 133, 183–188.
- Niléhn, J.-E., Nilsson, I. M., Aronsen, K.-F. & Ericsson, B. Studies on blood clotting factors in man after massive liver resection. Acta chir. scand. 1967, 133, 189–195.
- Olson, J. P., Miller, L. L. & Troup, S. B. Synthesis of clotting factors by the isolated perfused rat liver. J. clin. Invest. 1966, 45, 690–701.
- Owren, P. A. The diagnostic and prognostic significance of plasma prothrombin and factor V levels in parenchymatous hepatitis and obstructive jaundice. Scand. J. clin. Lab. Invest. 1949, 1, 131–140.
- Owren, P. A. Normotest in liver diseases. Farmakoterapi (Nyegaard & Co. A/S – Nyco – Oslo, Norway) 1969, 25, 46–59.
- Prokopowicz, J. Purification of plasminogen from human granulocytes using DEAE-Sephadex column chromatography. Biochim. biophys. Acta (Amst.) 1968, 154, 91–95.
- Rö, J. S. & Fiatmark, A. Studies on thrombin infusion in dogs. Scand. J. Haemat. 1972, 9, 293–304.
- Warner, E. D., Brinkhous, K. M. & Smith, H. P. A quantitative study on blood clotting: prothrombin fluctuations under experimental conditions. Amer. J. Physiol. 1936, 114, 667–675.
- Zucker, M. B., Siegel, M., Cliffton, E. E., Bellville, J. W., Howland, W. S. & Grossi, C. E. The effect of hepatic lobectomy on some blood clotting factors and on fibrinolysis. Ann. Surg. 1957, 146, 772–781.